Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
株式のランク #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
株価
$5.59
最終同期: 2026-09-02
時価総額
$205.21M
変化(1日)
6.27%
変化(1年)
86.33%
US
取引 Armata Pharmaceuticals, Inc. (ARMP)

カテゴリー

Armata Pharmaceuticals, Inc.(ARMP)の株価履歴
終値の最高値: $5.43 (2026-09-01)

終値の最安値: $435.94K (1994-05-01)
Armata Pharmaceuticals, Inc. の株価履歴(1994 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 13.52%
2025 190.05%
2024 -19.95%
2023 58.46%
2022 -67.90%
2021 72.26%
2020 -23.93%
2019 34.77%
2018 -79.83%
2017 -78.80%
2016 -90.19%
2015 -42.27%
2014 -62.10%
2013 143.79%
2012 51.63%
2011 -68.50%
2010 43.56%
2009 25.27%
2008 -87.80%
2007 -70.87%
2006 15.56%
2005 -67.75%
2004 -29.84%
2003 404.64%
2002 -82.93%
2001 -65.33%
2000 120.04%
1999 124.66%
1998 -44.75%
1997 -28.14%
1996 -25.02%
1995 26.21%
1994 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.05 -8.95%
AU
$757.71 6.76%
CH